Clinical research I. The importance of the research design
Main Article Content
Keywords
Research, Research design, Clinical trial
Abstract
The endeavor of clinical research to study a group of patients is to make a diagnosis, estimate the prognosis and prove a treatment. For this purpose it is used the scientific method: 1) the architectural arrangement, which can be divided in cause-effect and the process of research; 2) the methodological approach, it includes the controlled clinical trials, cohorts, case control, and cross-sectional designs; 3) the goal-oriented approach, in which the studies on diagnostic tests, prognosis, treatment and risk or causal factors are grouped. The designs above mentioned are considered primary studies; it means that the information was obtained directly from the subjects studied. There is a second category of studies, which uses information obtained from the primary studies. This is the reason why they are considered as secondary or integrative studies.
References
Cañedo DL. Investigación clínica. México: Interamericana; 1987.
Feinstein AR. Clinical epidemiology. The architecture of clinical research. Philadelphia: WB Sanders; 1985.
Feinstein AR. Directionality and scientific inference. J Clin Epidemiol 1989;42:829-833.
Feinstein AR. Scientific standards in epidemiologic studies of the menace of daily life. Science 1988;242:1257-1263.
Hernández-Ávila M, Garrido-Latorre F, López-Moreno S. Diseño de estudios epidemiológicos. Salud Publica Mex 2000;42:144-154.
Hughes M, Williams P. Challenges in using observational studies to evaluate adverse effects of treatment. NEJM 2007;356:1705-1707.
Hulley S, Cummings S. Designing clinical research. Philadelphia, USA: Lippincott Williams & Wilkins; 1988.
Kelsey J, Whitemoore A, Evans A, Thompson W. Methods in observational epidemiology. Second edition. New York, USA: Oxford University Press; 1996.
Meinert C. Clinical trials: design, conduct and analysis. New York, USA: Oxford University Press; 1986.
Interamericana-McGraw-Hill; 1994.
Petitti D. Meta-analysis, decision analysis and cost-effectiveness analysis: methods for quantitative synthesis in medicine. Second edition. New York, USA: Oxford University Press; 2000.
Schlesselman J. Case control studies: design, conduct, analysis. New York, USA: Oxford University Press; 1982.
Wacher N, Lifshitz A. Qué es la epidemiologia clínica y para que le sirve al clínico. Rev Med IMSS 1989;27:171-174.
Walker AM. Observation and inference. An introduction to the methods of epidemiology. Chestnut Hill, MA: Epidemiology Resources Inc.; 1991.
Weiss NS. Scientific standards in epidemiologic studies. Epidemiology 1990;1:85-86.
Cruz-Anguiano V, Talavera J, Vázquez L, Antonio A, Castellanos A, Lezana M, et al. The importance of quality of care in perinatal mortality: a population-based case-control study in Chiapas, Mexico. Arch Med Res 2004;35:554-562.
Brea-Andrés E, Aburto-Gudiño E, Vázquez-Estupiñán F, Nellen-Humel H, Talavera-Piña JO, Wacher-Rodarte N, et al. Incidencia de delirium y morbilidad asociada en medicina interna. Acta Psiquiátrica y Psicológica de América Latina 2000;46:359-362.
Talavera J, Wacher N, Laredo F, López A, Martínez V, González J, et al. A rating system for prompt clinical diagnosis of ischemic stroke. Arch Med Res 2000;31: 576-584.
Gómez-Díaz R, Martínez-Hernández A, Aguilar-Salinas C, Violante R, Alarcón A, et al. Percentile distribution of the waist circumference among Mexican pre-adolescents of a primary school in México City. Diabetes Obes Metab 2005;7:716-721.
González-Ortiz M, Guerrero-Romero JF, Violante-Ortiz R, Wacher-Rodarte N, Martínez-Abundis E, Aguilar-Salinas C, et al. Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus. J Diabetes Complications 2009;23: 376-379.
Gómez R, Aguilar-Salinas CA, Morán-Villota S, Barradas-González R. Herrera-Márquez R, Cruz M, et al. Lack of agreement between the revised criteria of impaired fasting glucose and impaired glucose tolerance in children with excess body weight. Diabetes Care 2004;27:2229-2233.
Pérez-Cuevas R, Reyes-Morales H, Flores-Hernández S, Wacher-Rodarte N. Efecto de una guía de práctica clínica para el manejo de la diabetes tipo 2. Rev Med Inst Mex Seguro Soc 2007;45(4):353-360.
Cruz M, Maldonado-Bernal C, Mondragón-González R, Sánchez-Barrera Wacher N, Carvajal-Sandoval, et al. Glycine treatment decreases proinflammatory cytokines and increases interfeon-g in patients with type 2 diabetes. J Endrocrinol Invest 2008;31:694-699.
Cruz M, García-Macedo I, García-Valerio Y, Gutiérrez M, Medina-Navarro R, Durán G, et al. Low adiponectin levels predict type 2 diabetes in Mexican children. Diabetes Care 2004:27:1451-1453.
Nellen H, Flores G, Wacher N. Treatment of human immunodeficiency virus enteropathie with a gluten-free diet. Arch Intern Med 2000;160:244.